Literature DB >> 2891517

Therapeutic results in cryptorchidism after combination therapy with LH-RH nasal spray and hCG.

J Waldschmidt1, M el-Dessouky, A Priefer.   

Abstract

Seventy-two boys with 81 cryptorchid testes were treated with combined LH-RH nasal spray and hCG in the period between 1983 and 1985. Cryptocur (LH-RH) was applied as nasal spray at a dose of 1.2 mg daily over a period of 14 days. In all of the patients, hCG treatment was carried out subsequently according to the WHO guidelines with five intramuscular injections at 2-day intervals. Primary treatment results considerably improved using the regimen. The rate of complete descent was 86.4% at the end of therapy and later dropped to 70.6% after 2 years follow-up. These results support the experience of Hadziselimovic et al. with this combined treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891517     DOI: 10.1007/bf00452866

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

1.  Treatment of cryptorchidism with pernasal gonadotropin-releasing hormone therapy.

Authors:  J Happ; F Kollmann; C Krawehl; M Neubauer; U Krause; K Demisch; J Sandow; W Von Rechenberg; J Beyer
Journal:  Fertil Steril       Date:  1978-05       Impact factor: 7.329

2.  [4 years' experience with combined hormonal treatment of cryptorchism].

Authors:  F Hadziselimović; J Girard; B Herzog
Journal:  Z Kinderchir       Date:  1984-10

3.  The role of the epididymis in testicular descent.

Authors:  D T Mininberg; S Schlossberg
Journal:  J Urol       Date:  1983-06       Impact factor: 7.450

4.  [Treatment of cryptorchism with LHRH nasal spray].

Authors:  M Borkenstein; V Zobel
Journal:  Wien Klin Wochenschr       Date:  1985-04-26       Impact factor: 1.704

5.  [The undescended testis].

Authors:  O Westphal; S Hagberg
Journal:  Monatsschr Kinderheilkd       Date:  1985-06       Impact factor: 0.323

6.  Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone.

Authors:  J Rajfer; D J Handelsman; R S Swerdloff; R Hurwitz; H Kaplan; T Vandergast; R M Ehrlich
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

7.  Therapeutic effects of luteinizing hormone releasing hormone (LH-RH) in cryptorchidism.

Authors:  G Bartsch; J Frick
Journal:  Andrologia       Date:  1974       Impact factor: 2.775

8.  Treatment of undescended testes with intranasal application of synthetic LH-RH.

Authors:  S Hagberg; O Westphal
Journal:  Eur J Pediatr       Date:  1982-12       Impact factor: 3.183

9.  Treatment of cryptorchidism with pulsatile luteinizing hormone-releasing hormone (LH-RH).

Authors:  E J Keogh; A MacKellar; S A Mallal; A G Dunn; S C McColm; C P Somerville; C Glatthaar; T Marshall; J Attikiouzel
Journal:  J Pediatr Surg       Date:  1983-06       Impact factor: 2.545

10.  Success, relapse and failure after intranasal LHRH treatment of cryptorchidism in 55 prepubertal boys.

Authors:  R Illig; H Bucher; A Prader
Journal:  Eur J Pediatr       Date:  1980-03       Impact factor: 3.183

View more
  3 in total

1.  The results of 9 years of experience with a combined treatment with LH-RH and HCG for cryptorchidism.

Authors:  J Waldschmidt; T Doede; I Vygen
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

2.  The influence of patency of the vaginal process on the efficacy of hormonal treatment of cryptorchidism.

Authors:  R Varela Cives; A Bautista Casasnovas; A Alonso Martin; M Pombo Arias; R Tojo Sierra
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

3.  The behavior of epididymis, processus vaginalis and testicular descent in cryptorchid boys treated with buserelin.

Authors:  D T Bica; F Hadziselimovic
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.